Background The effects of fourth‐generation drospirenone‐containing combined oral
contraceptives (COC s) on the risk of venous thromboembolism (VTE) are controversial …

Background Previous studies have provided conflicting results regarding the effect of
drospirenone‐containing oral contraceptive pills (OCP s) on the risk of venous and arterial …

Post-marketing surveillance of combined oral contraceptives (COCs) for rare complications
such as venous thromboembolism (VTE) presents unique challenges. Prospective studies …

OBJECTIVE: To review primary literature regarding the risk of venous thromboembolism
(VTE) in users of combined oral contraceptives (COCs) containing drospirenone compared …

Although the risk of venous thromboembolism is increased among oral contraceptive users
compared with nonusers who are not pregnant and not taking hormones, and some data …

Purpose The risk of venous thromboembolism (VTE) with drospirenone-containing oral
contraceptives (OCs) is reviewed. Summary Increasing attention and media have raised …

Background: Much scientific, media and patient interest surrounds the risk of venous
thromboembolism (VTE) in women taking combined oral contraceptives (COCs). Objectives …

Background: Combined oral contraceptives are a common method of contraception, but they
carry a risk of venous and arterial thrombosis. We assessed whether use of drospirenone …

Objective To examine the risk of non-fatal idiopathic venous thromboembolism in current
users of a combined oral contraceptive containing drospirenone, relative to current users of …

Introduction Substantial evidence suggests that drospirenone-containing oral contraceptives
may cause a higher risk of venous thrombotic events than earlier-generation oral …